GI hemorrhage with fulminant shock induced by jejunal gastrointestinal stromal tumor (GIST) coincident with duodenal neuroendocrine carcinoma (NET) plus neurofibromatosis (NF) -: Case report and review of the literature

被引:26
作者
Kramer, K [1 ]
Siech, M [1 ]
Sträter, J [1 ]
Aschoff, AJ [1 ]
Henne-Bruns, D [1 ]
机构
[1] Univ Ulm Klinikum, Chirurg Klin 1, D-89075 Ulm, Germany
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2005年 / 43卷 / 03期
关键词
GIST; NET; NF; hemorrhage;
D O I
10.1055/s-2004-813810
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The incidence of neuroendocrine tumors (NET) and of gastrointestinal stromal tumors (GIST) is 0.5 and 1 - 2 in 100,000; the prevalence of neurofibromatosis is 1 in 3000 live births in Western countries. Case Report: A 43-year-old white woman with a six-month history of meleana, paleness, vertigo. and fatigue was not referred to any gastrointestinal doctor for diagnostic work-up. Finally, she collapsed and was admitted to hospital because of an acute gastrointestinal bleeding. Endoscopically the source of bleeding could not be localized while blood in the duodenum and proximal jejunum was demonstrable. The source of bleeding could not be identified by endoscopy, CT scan or angiography. The patient developed a fulminant gastrointestinal hemorrhage with hemoglobin levels below 3.5 g%. An emergency laparotomy and pylorus-preventing Whipple operation was performed. Pathological studies showed a GIST with 3.5 cm diameter of the proximal jejunum which was the source of bleeding. Coincidentally a neuroendocrine carcinoma of the duodenum was found. Conclusion: This case is the first presentation of the coincidence of a neuroendocrine carcinoma of the duodenum with a jejunal bleeding gastrointestinal stromal tumor in neurofibromatosis type1 which led to hemorrhagic shock. In neurofibromatosis - even if non-symptomatic - the increased incidence of tumor needs to be considered.
引用
收藏
页码:281 / 288
页数:8
相关论文
共 57 条
  • [21] Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumors
    Faiss, S
    Räth, U
    Mansmann, U
    Caird, D
    Clemens, N
    Riecken, EO
    Wiedenmann, B
    [J]. DIGESTION, 1999, 60 (05) : 469 - 476
  • [22] Neurofibroma and schwannoma
    Ferner, RE
    O'Doherty, MJ
    [J]. CURRENT OPINION IN NEUROLOGY, 2002, 15 (06) : 679 - 684
  • [23] Von Recklinghausen disease and gastrointestinal stromal tumors
    Giuly, JA
    Picand, R
    Giuly, D
    Monges, B
    Nguyen-Cat, R
    [J]. AMERICAN JOURNAL OF SURGERY, 2003, 185 (01) : 86 - 87
  • [24] GRIFFITHS DFR, 1987, Q J MED, V64, P769
  • [25] FAMILIAL FIBROMATOSIS OF SMALL INTESTINE
    HASHEMIAN, H
    [J]. BRITISH JOURNAL OF SURGERY, 1953, 40 (162) : 346 - 350
  • [26] Heimann R, 1988, Neurofibromatosis, V1, P26
  • [27] Inhibition of KIT tyrosine kinase activity: A novel molecular approach to the treatment of KIT-positive malignancies
    Heinrich, MC
    Blanke, CD
    Druker, BJ
    Corless, CL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) : 1692 - 1703
  • [28] Hohenberger P, 2003, P AM SOC CLIN ONCOL, V22, P818
  • [29] Multidetector-row computed tomography and 3-dimensional computed tomography imaging of small bowel neoplasms - Current concept in diagnosis
    Horton, KM
    Fishman, EK
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2004, 28 (01) : 106 - 116
  • [30] Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
    Joensuu, H
    Roberts, PJ
    Sarlomo-Rikala, M
    Andersson, LC
    Tervahartiala, P
    Tuveson, D
    Silberman, SL
    Capdeville, R
    Dimitrijevic, S
    Druker, B
    Demetri, GD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1052 - 1056